Market Overview:
The global amyloid peptides market is expected to grow at a CAGR of xx% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of Alzheimer’s disease, cancer, and other diseases that are associated with amyloid peptide accumulation. In addition, the increasing demand for amyloid peptides for research purposes is also contributing to the growth of this market. The global amyloid peptides market can be segmented on the basis of type, application, and region. On the basis of type, it can be divided into beta-amyloid mouse, beta-amyloid rat, and beta-amyloid human. Beta-amyloids are proteins that are found in humans and other animals. They play an important role in normal brain function but may also contribute to Alzheimer’s disease when they form clumps or plaques outside cells in certain areas of the brain. On the basis of application, it can be classified into Alzheimer’s disease research, cancer research Lewy body dementia research inclusion body myositis (IBM)research cerebral amyloid angiopathy (CAA)research others).
Product Definition:
Amyloid peptides are a group of peptides that are produced by the proteolytic cleavage of amyloid precursor protein (APP). They play an important role in Alzheimer's disease, where they aggregate to form senile plaques.
Beta-Amyloid Mouse:
Beta-amyloid mouse is a specific type of transgenic animal model that exhibits amyloidosis, a disease similar to the one observed in humans. The primary difference between human and mice amyloids is their size; while humans have larger versions of the protein, called “A” proteins, found in their tissues (such as nerves), mice have smaller forms known as “B” proteins.
Beta-Amyloid Rat:
Beta-amyloid rat is a chemical that is produced by the body during an attempt to repair injured cells. The amyloids that are formed after the injury are not useful and instead of being discarded, they get swept into a holding pattern in between cells in the body. Over time, these amyloids can collect around 20 different proteins together to form what is called beta-amyloid plaques.
Application Insights:
Alzheimer's disease research segment held the largest share of revenue in 2017. The increasing prevalence of Alzheimer¢â‚¬â„¢s disease and the rising demand for effective therapeutics are some of the key factors driving this segment. Amyloid-based drugs have shown promising results in preclinical tests against Alzheimer¢â‚¬â„¢s pathology, which is expected to boost market growth during the forecast period.
Cerebral amyloid angiopathy (CAA) is estimated to be one of the fastest growing segments over the forecast period owing to its high incidence rate and wide spread awareness about it among healthcare professionals and patients worldwide. It has been observed that people suffering from mild cognitive impairment or dementia are more likely to develop CAA later in life, thus providing a potential opportunity for new drug development globally over next few years.
Regional Analysis:
North America held the largest share in 2017 owing to the presence of a substantial number of companies involved in manufacturing and providing products based on amyloid peptides. Moreover, these companies are engaged in R&D activities for developing novel therapies for treatment of Alzheimer's disease. Thus, increasing investments by major players and rising prevalence of this condition is anticipated to drive regional market growth over the forecast period.
Asia Pacific region is expected to witness lucrative growth during the forecast period due to growing geriatric population coupled with an increase in awareness about early diagnosis & treatment options for neurodegenerative diseases such as Alzheimer's & Parkinson's disease which are major applications associated with this region. Furthermore, availability at low cost makes it attractive as a research tool leading to increased demand from countries like Japan and China where healthcare expenditure is relatively lower than that observed in North America or Europe thus driving its usage across various research studies conducted within Asia Pacific region (APAC).
Growth Factors:
- Increasing research and development activities for the treatment of Alzheimer's disease (AD) and other amyloid-related disorders.
- Growing demand for early diagnosis and treatment of AD.
- Rising prevalence of AD across the globe.
- Increasing number of clinical trials for the development of novel therapies for AD patients
Scope Of The Report
Report Attributes
Report Details
Report Title
Amyloid Peptides Market Research Report
By Type
Beta-Amyloid Mouse, Beta-Amyloid Rat, Beta-Amyloid Human
By Application
Alzheimer's Disease Research, Cancer Research, Lewy Body Dementia Research, Inclusion Body Myositis Research, Cerebral Amyloid Angiopathy Research, Others
By Companies
rPeptide, AnaSpec, Inc, Genscript, BioLegend, NovoPro Inc., Bio-Synthesis, AmideBio, Cambridge Research Biochemicals, Bachem, rPeptide
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
202
Number of Tables & Figures
142
Customization Available
Yes, the report can be customized as per your need.
Global Amyloid Peptides Market Report Segments:
The global Amyloid Peptides market is segmented on the basis of:
Types
Beta-Amyloid Mouse, Beta-Amyloid Rat, Beta-Amyloid Human
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Alzheimer's Disease Research, Cancer Research, Lewy Body Dementia Research, Inclusion Body Myositis Research, Cerebral Amyloid Angiopathy Research, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- rPeptide
- AnaSpec, Inc
- Genscript
- BioLegend
- NovoPro Inc.
- Bio-Synthesis
- AmideBio
- Cambridge Research Biochemicals
- Bachem
- rPeptide
Highlights of The Amyloid Peptides Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Beta-Amyloid Mouse
- Beta-Amyloid Rat
- Beta-Amyloid Human
- By Application:
- Alzheimer's Disease Research
- Cancer Research
- Lewy Body Dementia Research
- Inclusion Body Myositis Research
- Cerebral Amyloid Angiopathy Research
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Amyloid Peptides Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Amyloid peptides are a type of protein that can form amyloid plaques in the brain. Amyloid plaques are deposits of proteins that can damage the cells in the brain and lead to memory loss, cognitive decline, and other problems.
Some of the major players in the amyloid peptides market are rPeptide, AnaSpec, Inc, Genscript, BioLegend, NovoPro Inc., Bio-Synthesis, AmideBio, Cambridge Research Biochemicals, Bachem, rPeptide.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Amyloid Peptides Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Amyloid Peptides Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Amyloid Peptides Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Amyloid Peptides Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Amyloid Peptides Market Size & Forecast, 2018-2028
4.5.1 Amyloid Peptides Market Size and Y-o-Y Growth
4.5.2 Amyloid Peptides Market Absolute $ Opportunity
Chapter 5 Global Amyloid Peptides Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Amyloid Peptides Market Size Forecast by Type
5.2.1 Beta-Amyloid Mouse
5.2.2 Beta-Amyloid Rat
5.2.3 Beta-Amyloid Human
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Amyloid Peptides Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Amyloid Peptides Market Size Forecast by Applications
6.2.1 Alzheimer's Disease Research
6.2.2 Cancer Research
6.2.3 Lewy Body Dementia Research
6.2.4 Inclusion Body Myositis Research
6.2.5 Cerebral Amyloid Angiopathy Research
6.2.6 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Amyloid Peptides Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Amyloid Peptides Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Amyloid Peptides Analysis and Forecast
9.1 Introduction
9.2 North America Amyloid Peptides Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Amyloid Peptides Market Size Forecast by Type
9.6.1 Beta-Amyloid Mouse
9.6.2 Beta-Amyloid Rat
9.6.3 Beta-Amyloid Human
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Amyloid Peptides Market Size Forecast by Applications
9.10.1 Alzheimer's Disease Research
9.10.2 Cancer Research
9.10.3 Lewy Body Dementia Research
9.10.4 Inclusion Body Myositis Research
9.10.5 Cerebral Amyloid Angiopathy Research
9.10.6 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Amyloid Peptides Analysis and Forecast
10.1 Introduction
10.2 Europe Amyloid Peptides Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Amyloid Peptides Market Size Forecast by Type
10.6.1 Beta-Amyloid Mouse
10.6.2 Beta-Amyloid Rat
10.6.3 Beta-Amyloid Human
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Amyloid Peptides Market Size Forecast by Applications
10.10.1 Alzheimer's Disease Research
10.10.2 Cancer Research
10.10.3 Lewy Body Dementia Research
10.10.4 Inclusion Body Myositis Research
10.10.5 Cerebral Amyloid Angiopathy Research
10.10.6 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Amyloid Peptides Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Amyloid Peptides Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Amyloid Peptides Market Size Forecast by Type
11.6.1 Beta-Amyloid Mouse
11.6.2 Beta-Amyloid Rat
11.6.3 Beta-Amyloid Human
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Amyloid Peptides Market Size Forecast by Applications
11.10.1 Alzheimer's Disease Research
11.10.2 Cancer Research
11.10.3 Lewy Body Dementia Research
11.10.4 Inclusion Body Myositis Research
11.10.5 Cerebral Amyloid Angiopathy Research
11.10.6 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Amyloid Peptides Analysis and Forecast
12.1 Introduction
12.2 Latin America Amyloid Peptides Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Amyloid Peptides Market Size Forecast by Type
12.6.1 Beta-Amyloid Mouse
12.6.2 Beta-Amyloid Rat
12.6.3 Beta-Amyloid Human
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Amyloid Peptides Market Size Forecast by Applications
12.10.1 Alzheimer's Disease Research
12.10.2 Cancer Research
12.10.3 Lewy Body Dementia Research
12.10.4 Inclusion Body Myositis Research
12.10.5 Cerebral Amyloid Angiopathy Research
12.10.6 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Amyloid Peptides Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Amyloid Peptides Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Amyloid Peptides Market Size Forecast by Type
13.6.1 Beta-Amyloid Mouse
13.6.2 Beta-Amyloid Rat
13.6.3 Beta-Amyloid Human
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Amyloid Peptides Market Size Forecast by Applications
13.10.1 Alzheimer's Disease Research
13.10.2 Cancer Research
13.10.3 Lewy Body Dementia Research
13.10.4 Inclusion Body Myositis Research
13.10.5 Cerebral Amyloid Angiopathy Research
13.10.6 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Amyloid Peptides Market: Competitive Dashboard
14.2 Global Amyloid Peptides Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 rPeptide
14.3.2 AnaSpec, Inc
14.3.3 Genscript
14.3.4 BioLegend
14.3.5 NovoPro Inc.
14.3.6 Bio-Synthesis
14.3.7 AmideBio
14.3.8 Cambridge Research Biochemicals
14.3.9 Bachem
14.3.10 rPeptide
